2407 — Gaush Meditech Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapContrarian

Annual cashflow statement for Gaush Meditech, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	PROSPECTUS	PROSPECTUS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	149	-138	-275	248	155
Depreciation
Amortisation
Non-Cash Items	41.9	420	541	39.4	63.7
Unusual Items
Other Non-Cash Items
Changes in Working Capital	-73.4	-177	-97.3	-114	-193
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	130	164	234	249	108
Capital Expenditures	-1.82	-28	-48	-45.6	-81.2
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	-996	108	-88	-122	99.8
Acquisition of Business
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	-998	79.8	-136	-168	18.5
Financing Cash Flow Items	-2.17	-86.7	-42.5	-46.3	-33.9
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	856	72.8	3.08	-190	-303
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	-25.3	302	113	-103	-197